[OH:1][N:2]1[C:10]2[C:5](=[CH:6][CH:7]=[C:8]([N+:11]([O-:13])=[O:12])[CH:9]=2)[CH2:4][C:3]1=[O:14].[C:15]([O:18][C:19](=O)[CH3:20])(=O)[CH3:16]>CCOC(OCC)(OCC)C1C=CC=CC=1>[C:3]([O:1][N:2]1[C:10]2[C:5](=[CH:6][CH:7]=[C:8]([N+:11]([O-:13])=[O:12])[CH:9]=2)[C:4](=[C:15]([O:18][CH2:19][CH3:20])[C:16]2[CH:9]=[CH:10][CH:5]=[CH:6][CH:7]=2)[C:3]1=[O:14])(=[O:14])[CH3:4]300 mg of 1-hydroxy-6-nitro-2-indolinone are dissolved in 4.0 ml of acetic anhydride and 4.0 ml of triethyl orthobenzoate, stirred for 6 hours at 110° C., concentrated by evaporation and purified through a silica gel column with methylene chloride as eluant.